Page last updated: 2024-11-02

orphenadrine and Encephalitis Lethargica Type Parkinsonism

orphenadrine has been researched along with Encephalitis Lethargica Type Parkinsonism in 3 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MASCIOCCHI, A1
SFRONDINI, E1
Stern, G1

Other Studies

3 other studies available for orphenadrine and Encephalitis Lethargica Type Parkinsonism

ArticleYear
[Disipal in the treatment of post-encephalitic parkinsonism].
    Rassegna di neuropsichiatria e scienze affini, 1958, Volume: 12, Issue:3-4

    Topics: Diphenhydramine; Encephalitis; Humans; Orphenadrine; Parkinson Disease; Parkinson Disease, Postencep

1958
Parkinsonism and dopa.
    The New Zealand medical journal, 1969, Volume: 69, Issue:444

    Topics: Dihydroxyphenylalanine; Humans; New Zealand; Orphenadrine; Parkinson Disease; Parkinson Disease, Pos

1969
Parkinsonism.
    British medical journal, 1969, Nov-29, Volume: 4, Issue:5682

    Topics: Agranulocytosis; Dihydroxyphenylalanine; Humans; Middle Aged; Nausea; Orphenadrine; Parasympatholyti

1969